Eurobloodnet Association — Sponsor Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

2 Recruiting

0 Completed trials

4 Countries active

2 Unique IMPs

N/A Results reported

Phase II

Top IMPs

2 total

LUSPARA - Luspatercept in patients affected with rare inherited anemias Recruiting

2024-520200-26-00 Phase II 2 countries LUSPATERCEPT
Mitapivat in Membranopathies Recruiting

2023-503271-24-01 Phase II 2 countries MITAPIVAT

Showing 1–2 of 2 trials